SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001833141-24-000015
Filing Date
2024-08-19
Accepted
2024-08-16 20:37:58
Documents
18
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 6-K/A cybin-form6xkaaugust2024.htm 6-K/A 18636
2 EX-99.,2 abridgementcertificatecybi.htm EX-99.,2 6241
3 EX-99.1 agm2024-managementinformat.htm EX-99.1 648419
4 EX-99.3 proxyformcybin-july2024.htm EX-99.3 39622
5 EX-99.4 cybininc-noticeofannualand.htm EX-99.4 14903
6 GRAPHIC image_0.jpg GRAPHIC 345
7 GRAPHIC image_0a.jpg GRAPHIC 89926
8 GRAPHIC image_0b.jpg GRAPHIC 167
9 GRAPHIC image_0c.jpg GRAPHIC 39500
10 GRAPHIC image_1.jpg GRAPHIC 76018
11 image_1a.jpg GRAPHIC 3340
12 GRAPHIC image_2.jpg GRAPHIC 57515
13 GRAPHIC image_3.jpg GRAPHIC 139631
14 GRAPHIC image_4.jpg GRAPHIC 133883
15 GRAPHIC image_5.jpg GRAPHIC 155533
16 GRAPHIC image_6.jpg GRAPHIC 166926
17 GRAPHIC image_7.jpg GRAPHIC 102644
18 GRAPHIC image_8.jpg GRAPHIC 21143
  Complete submission text file 0001833141-24-000015.txt   2089321
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K/A | Act: 34 | File No.: 001-40673 | Film No.: 241218050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)